CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- Open-market buys, last 90 days
- $6,396,312
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$6,396,312. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-17 | MCGAULEY THOMAS Interim CFO | Purchase | +1,000 | $7.35 | $7K | 1,000 |
| 2025-11-17 | MCGAULEY THOMAS Interim CFO | Purchase | +5,000 | $7.23 | $36K | 5,000 |
| 2025-11-17 | Almenoff June Sherie Director | Purchase | +93 | $7.15 | $665 | 93 |
| 2025-07-01 | Almenoff June Sherie Director | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2025-07-01 | Davidson Michael H. Director | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2025-07-01 | Doogan Declan Director | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2025-07-01 | PROEHL GERALD T Director | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2025-07-01 | Hunter Robyn Director | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2025-05-16 | Rich Stuart Chief Medical Officer | Grant or award · Stock Option (right to buy) | +625,000 | 625,000 | ||
| 2025-05-16 | Giordano Christopher Thomas CEO | Grant or award · Stock Option (right to buy) | +1,400,000 | 1,400,000 | ||
| 2024-12-10 | Rich Stuart Chief Medical Officer | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2024-12-10 | PROEHL GERALD T Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-12-10 | Hunter Robyn Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-12-10 | Giordano Christopher Thomas CEO | Grant or award · Stock Option (right to buy) | +1,250,000 | 1,250,000 | ||
| 2024-12-10 | Doogan Declan Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-12-10 | Davidson Michael H. Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-12-10 | Almenoff June Sherie Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-08-08 | PROEHL GERALD T Director | Purchase | +1,666 | 1,667 | ||
| 2024-08-08 | PROEHL GERALD T Director | Purchase · Pre-Funded Warrant | +31,654 | 31,654 | ||
| 2024-08-08 | PROEHL GERALD T Director | Purchase · Warrant | +16,660 | 16,660 |
Page 3 of 9 · 172 trades